CBP completes operation No Tox
With the help of the Food and Drug Administration (FDA), US Customs and Border Protection (CBP) officers at the Louisville Port of Entry intercepted more than 700 unapproved Botox and derma fillers during Operation No Tox from 10 -14 April 2023.
CBP officers focused on suspect shipments of Botox imported without FDA approved licence, permit, authorisation, or prescription attempting entry into USA. The officers’ primary focus was on merchandise exported from South Korea, Malaysia, Indonesia, and Turkey described as lotions, creams, skin care and other related merchandise.
During these five days CBP officers stopped 150 shipments that contained 744 unapproved, misbranded, counterfeit, fraudulent, and otherwise illicit Botox, and other brands of Botulinum Toxin Type A products, as well as derma fillers.
Additionally, prior to this operation, CBP officers in Louisville had made over 100 Botox seizures since 1 October 2022. (cj)